Gameto

Biotechnology · Austin, TX · Founded 2020 · Privately Held (backing)

Operator of a biotechnology company intended to solve diseases of the female reproductive system. Gameto is based in Austin, TX and was founded in 2020. It was valued at $243 million at its later-stage round in Aug 2025, the last priced event on record. It has raised $127 million across 2 recorded rounds; the latest was a $44 million Series C in Aug 2025.

PMV mark · valuation
$243.0M
Oct 2026
Priced at
its later-stage round
Aug 2025
Total raised
$127.0M
Last round
Later Stage VC (Series C)
Aug 2025
What is Gameto worth?
$243.0MPrivateMarketView mark · Oct 2026

Valued at $243.0M at its later-stage round, Aug 2025. Nothing has traded since.

Free account
More of Gameto with a free account
  • ·The complete investor list: 49 names
  • ·Watch Gameto: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Valuation timeline

0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026
▮▮
Markrounds hold their value until the next priced eventMark, today
log scale
Post-money values unlock with a free account.Unlock the axis

Membership and data by Private Market View

Gameto funding history

2 rounds
DateRoundRaisedPost-money
Aug 2025Later Stage VC (Series C)$44.0M▮
May 2024Early Stage VC (Series B)$43.0M▮
Unlock post-money valuations

Membership and data by Private Market View

Gameto valuation

Gameto was valued at $243 million at its later-stage round in Aug 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Gameto raised?

Gameto has raised $127 million in total; 2 of its rounds are on record. The largest on record was a $44 million Series C in Aug 2025.

Gameto has filed 2 Form Ds with the SEC since 2024, most recently in Aug 2025 ($44 million sold to 22 investors).

Comparable companies

Comparable biotechnology names by valuation on PrivateMarketView: Ansa Biotechnologies ($269 million), Ambros Therapeutics ($250 million) and Antheia ($240 million).

How Gameto's valuation is determined

Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.

For Gameto, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →

Frequently asked about Gameto

What is Gameto worth?
Gameto is valued at $243.0M as of Oct 2026. Valued at $243.0M at its later-stage round, Aug 2025. Nothing has traded since.
How much has Gameto raised?
Gameto has raised $127.0M in total funding across 2 recorded rounds.
When did Gameto last raise?
Gameto last raised in Aug 2025 (Later Stage VC (Series C)), raising $44.0M.